Screening for Lynch Syndrome Beneficial at Acceptable Cost

Women in particular could increase life expectancy with screening, prophylactic surgery

TUESDAY, July 19 (HealthDay News) -- Identifying families with the Lynch syndrome could yield considerable benefits at acceptable costs, particularly for women, according to a study published online July 18 in the Annals of Internal Medicine.

Uri Ladabaum, M.D., from the Stanford University School of Medicine in Calif., and colleagues investigated the efficacy and cost-effectiveness of strategies to identify and treat the Lynch syndrome in individuals with newly diagnosed colorectal cancer and their relatives. Cost-effectiveness was estimated using the Markov model which incorporated risk for colorectal, endometrial, and ovarian cancer. Intervention strategies were based on clinical criteria and included testing followed by tailored screening, and risk-reducing surgery. The main outcome measures were life-years, cancer cases and deaths, costs, and incremental cost-effectiveness ratios.

The investigators found that the primary beneficiaries of all strategies were the relatives, particularly females, with a mutation associated with the Lynch syndrome. These women's life expectancies could increase by four years by undergoing hysterectomy, salpingo-oophorectomy, and regular colorectal cancer screenings. Deaths from colorectal and endometrial/ovarian cancer were reduced by 7 to 42 percent and 1 to 6 percent, respectively, by implementing current strategies. Immunochemistry followed by BRAF mutation testing had an incremental cost-effectiveness ratio of $36,200 per life-year gained. Implementation of this screening up to age 70 years cost $44,000 per incremental life-year gained, compared with screening only up to age 60 years; and screening without an upper age limit compared to up to age 70 years cost $88,700 per incremental life-year gained. For most strategies, testing of three to four relatives was required to meet a threshold of $50,000 per life-year gained.

"Widespread colorectal tumor testing to identify families with the Lynch syndrome could yield substantial benefits at acceptable costs," the authors write.

Two authors disclosed financial ties to the medical device and health care industries.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95

The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95

Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.

Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.

Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events